Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
398
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Regarding “Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic”

Hinpetch Daungsupawonga Private Academic Consultant, Phonhong, Lao People’s Democratic RepublicCorrespondence[email protected]
View further author information
&
Viroj Wiwanitkitb Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IndiaView further author information
Article: 2354011 | Received 17 Apr 2024, Accepted 08 May 2024, Published online: 24 May 2024

References

  • Sun X, Wang W. Reply to the enhancing the accuracy of seroprevalence studies: reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic. Hum Vaccin Immunother. 2024; 20(1):2349321. doi: 10.1080/21645515.2024.2349321.
  • Daungsupawong H, Wiwanitkit V. Enhancing the accuracy of seroprevalence studies: reassessing pertussis infection rates in eastern China during the COVID-19 pandemic. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2340765. doi: 10.1080/21645515.2024.2340765.
  • Sun X, Zhang T, Sun J, Zhou J, Chen Q, Jia C, Xu Y, Wu Y, Wang Z, Wang W. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2331438. doi: 10.1080/21645515.2024.2331438.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.